Cover Image
Market Research Report
Product code 
969353

Big Data and AI in Market Access

Published: | FirstWord | Delivery time: 1-2 business days

Price

Back to Top
Big Data and AI in Market Access
Published: November 6, 2020
FirstWord
Delivery time: 1-2 business days
  • Description
  • Table of Contents

How is big data+AI technology driving market access strategy and practice?

Juggling the demands of multiple stakeholders for evidence of utility and value, while harnessing the insights from an ever-growing number of diverse data sources, has created a mounting workload for market access teams-and COVID-19 has not helped. To ease the pressure, many companies have implemented artificial intelligence (AI) and machine learning technologies to process big data sets. Outcomes have seen faster analysis of clinical trial data, identification of RWE gaps and the agile generation of evidence to meet HTA and other stakeholder requirements. So, what's next for advanced AI analytics and what key trends should market access planners be following?

To examine in detail this critical area of pharma's business we interviewed pharma and market access experts. In ‘Big Data and AI in Market Access ’they reveal the applications and strategies that are delivering clinical, operational and commercial wins across the market access spectrum.

Experts explore key questions:

  • In what areas are pharma innovatively utilizing big data and AI to influence their clinical and commercial market access strategies?
  • To what degree has AI impacted comparative effectiveness/RWE data analytics in respect to pricing and reimbursement decision making?
  • How are pharma using multimedia big data to profile, target and engage with KOLs/Rx Influencers, pharmacies and payers?
  • In what ways is AI being applied by payers for assessing the potential cost-effectiveness of a drug and to determine its long-term budget impact?
  • What are the key AI and big data lessons pharma need to learn to effectively build, communicate and deliver value to key market access influencers and decision makers?
Product Code: 596201548

Table of Contents

Subject synopsis

Research methodology and objectives

Key insights summary

Issues and insights

  • Current market access landscape
    • Issue summary
    • Questions
    • Key insights
    • Supporting quotes
    • Intelligence exhibits
  • Application of big data and AI to clinical MA strategies
    • Issue summary
    • Questions
    • Key insights
    • Supporting quotes
    • Intelligence exhibits
  • Application of big data and AI to commercial market access
    • Issue summary
    • Questions
    • Key insights
    • Supporting quotes
    • Intelligence exhibits
  • Challenges when implementing AI and big data in market access programmes
    • Issue summary
    • Questions
    • Key insights
    • Supporting quotes
    • Intelligence exhibits
  • Future opportunities to utilise AI and big data to drive market access
    • Issue summary
    • Questions
    • Key insights
    • Supporting quotes
    • Intelligence exhibits

Abbreviations

Further reading